Submission of Matters to a Vote of Security Holders Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 26, 2024, Janux Therapeutics, Inc. (the "Company") held the Company's 2024 Annual Meeting of Stockholders (the "Annual Meeting"). As of April 29, 2024, the record date for the Annual Meeting, 51,850,667 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below. Voting results are, when applicable, reported by rounding fractional share voting down to the nearest round number.

Proposal 1: Election of Directors

The Company's stockholders elected the three persons listed below as Class III directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal. The final voting results are as follows:

Name of Director Elected		Votes For		Votes Withheld		Broker Non-Votes
Vickie Capps		48,034,233		98,744		1,671,776
Jay Lichter, Ph.D.		46,352,481		1,698,166		1,754,106
Jake Simson, Ph.D.		41,538,424		6,589,319		1,677,010

Proposal 2: Ratification of the Selection of Independent Registered Public Accounting Firm

The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The final voting results are as follows:

Votes For		Votes Against		Abstentions		Broker Non-Votes
49,801,743		1,682		1,328		-

Public link

Please use the above public link if you want to share this noodl on another website.